382 related articles for article (PubMed ID: 3877776)
1. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism.
Ljunggren HG; Kärre K
J Exp Med; 1985 Dec; 162(6):1745-59. PubMed ID: 3877776
[TBL] [Abstract][Full Text] [Related]
2. Afferent and efferent cellular interactions in natural resistance directed against MHC class I deficient tumor grafts.
Ljunggren HG; Ohlén C; Höglund P; Yamasaki T; Klein G; Kärre K
J Immunol; 1988 Jan; 140(2):671-8. PubMed ID: 3335786
[TBL] [Abstract][Full Text] [Related]
3. Experimental strategies and interpretations in the analysis of changes in MHC gene expression during tumour progression. Opposing influences of T cell and natural killer mediated resistance?
Ljunggren HG; Kärre K
J Immunogenet; 1986; 13(2-3):141-51. PubMed ID: 3493296
[TBL] [Abstract][Full Text] [Related]
4. [Experimental analysis of intracerebral natural resistance against H-2+ and H-2- lymphomas grafted into the brain].
Yamasaki T; Kikuchi H; Yamashita J; Ljunggren HG; Karre K; Klein G
No Shinkei Geka; 1989 Aug; 17(8):717-23. PubMed ID: 2586713
[TBL] [Abstract][Full Text] [Related]
5. Hybrid resistance to EL-4 lymphoma cells. I. Characterization of natural killer cells that lyse EL-4 cells and their distinction from marrow-dependent natural killer cells.
Kumar V; Luevano E; Bennett M
J Exp Med; 1979 Sep; 150(3):531-47. PubMed ID: 383877
[TBL] [Abstract][Full Text] [Related]
6. H-2Kb antigen expression has no effect on natural killer susceptibility and tumorigenicity of a murine hepatoma.
Nishimura MI; Stroynowski I; Hood L; Ostrand-Rosenberg S
J Immunol; 1988 Dec; 141(12):4403-9. PubMed ID: 3264312
[TBL] [Abstract][Full Text] [Related]
7. Natural resistance against tumors grafted into the brain in association with histocompatibility-class-I-antigen expression.
Yamasaki T; Akiyama Y; Fukuda M; Kimura Y; Moritake K; Kikuchi H; Ljunggren HG; Kärre K; Klein G
Int J Cancer; 1996 Jul; 67(3):365-71. PubMed ID: 8707410
[TBL] [Abstract][Full Text] [Related]
8. YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage.
Piontek GE; Taniguchi K; Ljunggren HG; Grönberg A; Kiessling R; Klein G; Kärre K
J Immunol; 1985 Dec; 135(6):4281-8. PubMed ID: 3905967
[TBL] [Abstract][Full Text] [Related]
9. Selective depletion of NK cell activity in vivo and its effect on the growth of NK-sensitive and NK-resistant tumor cell variants.
Kawase I; Urdal DL; Brooks CG; Henney CS
Int J Cancer; 1982 May; 29(5):567-74. PubMed ID: 7095901
[TBL] [Abstract][Full Text] [Related]
10. Experimental appraisal of the lack of antitumor natural killer cell-mediated immunosurveillance in response to lymphomas growing in the mouse brain.
Yamasaki T; Moritake K; Klein G
J Neurosurg; 2003 Mar; 98(3):599-606. PubMed ID: 12650434
[TBL] [Abstract][Full Text] [Related]
11. Natural resistance against lymphoma grafts conveyed by H-2Dd transgene to C57BL mice.
Höglund P; Ljunggren HG; Ohlén C; Ahrlund-Richter L; Scangos G; Bieberich C; Jay G; Klein G; Kärre K
J Exp Med; 1988 Oct; 168(4):1469-74. PubMed ID: 3171481
[TBL] [Abstract][Full Text] [Related]
12. Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus.
Shouval D; Rager-Zisman B; Quan P; Shafritz DA; Bloom BR; Reid LM
J Clin Invest; 1983 Aug; 72(2):707-17. PubMed ID: 6192149
[TBL] [Abstract][Full Text] [Related]
13. Alteration of the natural killer repertoire in H-2 transgenic mice: specificity of rapid lymphoma cell clearance determined by the H-2 phenotype of the target.
Höglund P; Glas R; Ohlén C; Ljunggren HG; Kärre K
J Exp Med; 1991 Aug; 174(2):327-34. PubMed ID: 1856626
[TBL] [Abstract][Full Text] [Related]
14. Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. I. Effect of incompatibilities at H-2 or non-H-2 genes in normal and nude (nu/nu) mice.
Schirrmacher V
Invasion Metastasis; 1981; 1(1):4-21. PubMed ID: 7188381
[TBL] [Abstract][Full Text] [Related]
15. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.
Kärre K; Ljunggren HG; Piontek G; Kiessling R
Nature; 1986 Feb 20-26; 319(6055):675-8. PubMed ID: 3951539
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
[TBL] [Abstract][Full Text] [Related]
17. Natural resistance of lethally irradiated F1 hybrid mice to parental marrow grafts is a function of H-2/Hh-restricted effectors.
Daley JP; Nakamura I
J Exp Med; 1984 Apr; 159(4):1132-48. PubMed ID: 6368735
[TBL] [Abstract][Full Text] [Related]
18. Thymus independence of hybrid resistance against a panel of T-cell lymphomas of H-2b origin.
Klein GO; Kärre K; Kiessling R; Klein G
Int J Cancer; 1982 Nov; 30(5):659-62. PubMed ID: 6984022
[TBL] [Abstract][Full Text] [Related]
19. Resistance of metastatic tumor variants to tumor-specific cytotoxic T-lymphocytes not due to defects in expression of restricting major histocompatibility complex molecules in murine cells.
Altevogt P; Leidig S; Heckl-Oestreicher B
Cancer Res; 1984 Nov; 44(11):5305-13. PubMed ID: 6333273
[TBL] [Abstract][Full Text] [Related]
20. In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice.
Habu S; Fukui H; Shimamura K; Kasai M; Nagai Y; Okumura K; Tamaoki N
J Immunol; 1981 Jul; 127(1):34-8. PubMed ID: 7240748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
